C. Nichols

Corporate Officer/Principal at ALKERMES PLC

Net worth: 2 M $ as of 2024-03-30

Health Technology

Consumer Services

Profile

C.
Todd Nichols is currently the Chief Commercial Officer & Senior Vice President at Alkermes Plc.
Prior to his current position, he served as the Senior Vice President-Sales & Marketing at Alkermes, Inc. from 2019 to 2020.
Before that, he was the Vice President-Marketing & Sales at Celgene Corp.
from 2018 to 2019.
He also held a position as Vice President-US Sales & Field Operation at Biogen, Inc. Mr. Nichols completed his undergraduate degree at Elon University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ALKERMES PUBLIC LIMITED COMPANY 0.04%	2024-03-17	65,911 ( 0.04% )	2 M $	2024-03-30

C. Nichols active positions

Companies	Position	Start
ALKERMES PLC	Corporate Officer/Principal	-

All active positions of C. Nichols

Former positions of C. Nichols

Companies	Position	End
Alkermes, Inc. Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA.	Sales & Marketing	2020-04-30
CELGENE	Sales & Marketing	2018-12-31
BIOGEN INC.	Sales & Marketing	2016-12-31

See the detail of C. Nichols's experience

Training of C. Nichols

Elon University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of C. Nichols's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
BIOGEN INC.	Health Technology
ALKERMES PLC	Health Technology

Private companies	2
Alkermes, Inc. Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA.	Health Technology
Celgene Corp. Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.	Health Technology